|  Help  |  About  |  Contact Us

Publication : Exploration of beta-arrestin isoform signaling pathways in delta opioid receptor agonist-induced convulsions.

First Author  Blaine AT Year  2022
Journal  Front Pharmacol Volume  13
Pages  914651 PubMed ID  36059958
Mgi Jnum  J:328330 Mgi Id  MGI:7335503
Doi  10.3389/fphar.2022.914651 Citation  Blaine AT, et al. (2022) Exploration of beta-arrestin isoform signaling pathways in delta opioid receptor agonist-induced convulsions. Front Pharmacol 13:914651
abstractText  The delta-opioid receptor (deltaOR) has been considered as a therapeutic target in multiple neurological and neuropsychiatric disorders particularly as deltaOR agonists are deemed safer alternatives relative to the more abuse-liable micro-opioid receptor drugs. Clinical development of deltaOR agonists, however, has been challenging in part due to the seizure-inducing effects of certain deltaOR agonists. Especially agonists that resemble the deltaOR-selective agonist SNC80 have well-established convulsive activity. Close inspection suggests that many of those seizurogenic deltaOR agonists efficaciously recruit beta-arrestin, yet surprisingly, SNC80 displays enhanced seizure activity in beta-arrestin 1 knockout mice. This finding led us to hypothesize that perhaps beta-arrestin 1 is protective against, whereas beta-arrestin 2 is detrimental for deltaOR-agonist-induced seizures. To investigate our hypothesis, we characterized three different deltaOR agonists (SNC80, ADL5859, ARM390) in cellular assays and in vivo in wild-type and beta-arrestin 1 and beta-arrestin 2 knockout mice for seizure activity. We also investigated downstream kinases associated with beta-arrestin-dependent signal transduction. We discovered that deltaOR agonist-induced seizure activity strongly and positively correlates with beta-arrestin 2 efficacy for the agonist, but that indirect inhibition of ERK activation using the MEK inhibitor SL327 did not inhibit seizure potency and duration. Inhibition of the PI3K/AKT/mTOR signaling with honokiol but not PQR530, attenuated SNC80 seizure duration in beta-arrestin 1 knockout, but honokiol did not reduce SNC80-induced seizures in wild-type mice. Ultimately, our results indicate that beta-arrestin 2 is correlated with deltaOR agonist-induced seizure intensity, but that global beta-arrestin 1 knockout mice are a poor model system to investigate their mechanism of action.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

3 Bio Entities

Trail: Publication

0 Expression